144 related articles for article (PubMed ID: 38490654)
1. Impact of chronic oral glucocorticoid treatment on mortality in patients with COVID-19: analysis of a population-based cohort.
Einarsdottir MJ; Kibiwott Kirui B; Li H; Olsson D; Johannsson G; Nyberg F; Ragnarsson O
BMJ Open; 2024 Mar; 14(3):e080640. PubMed ID: 38490654
[TBL] [Abstract][Full Text] [Related]
2. High Mortality Rate in Oral Glucocorticoid Users: A Population-Based Matched Cohort Study.
Einarsdottir MJ; Ekman P; Molin M; Trimpou P; Olsson DS; Johannsson G; Ragnarsson O
Front Endocrinol (Lausanne); 2022; 13():918356. PubMed ID: 35872995
[TBL] [Abstract][Full Text] [Related]
3. Trends in long-term glucocorticoid use and risk of 5-year mortality: a historical cohort study in South Korea.
Oh TK; Song IA
Endocrine; 2020 Sep; 69(3):634-641. PubMed ID: 32557330
[TBL] [Abstract][Full Text] [Related]
4. Undiagnosed adrenal insufficiency as a cause of premature death in glucocorticoid users.
Einarsdottir MJ; Trimpou P; Johannsson G; Ragnarsson O
Endocr Connect; 2024 Apr; 13(4):. PubMed ID: 38428141
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
[TBL] [Abstract][Full Text] [Related]
7. Incidence of symptomatic vertebral fractures in women of childbearing age newly treated with high-dose glucocorticoid.
Sugiyama T; Suzuki S; Yoshida T; Suyama K; Tanaka T; Sueishi M; Tatsuno I
Gend Med; 2010 Jun; 7(3):218-29. PubMed ID: 20638627
[TBL] [Abstract][Full Text] [Related]
8. Oral glucocorticoid therapy and all-cause and cause-specific mortality in patients with rheumatoid arthritis: a retrospective cohort study.
Movahedi M; Costello R; Lunt M; Pye SR; Sergeant JC; Dixon WG
Eur J Epidemiol; 2016 Oct; 31(10):1045-1055. PubMed ID: 27256352
[TBL] [Abstract][Full Text] [Related]
9. High prescription rate of oral glucocorticoids in children and adults: A retrospective cohort study from Western Sweden.
Einarsdottir MJ; Ekman P; Trimpou P; Olsson DS; Johannsson G; Ragnarsson O
Clin Endocrinol (Oxf); 2020 Jan; 92(1):21-28. PubMed ID: 31631358
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study.
Pujades-Rodriguez M; Morgan AW; Cubbon RM; Wu J
PLoS Med; 2020 Dec; 17(12):e1003432. PubMed ID: 33270649
[TBL] [Abstract][Full Text] [Related]
11. Exposure measurement error when assessing current glucocorticoid use using UK primary care electronic prescription data.
Joseph RM; van Staa TP; Lunt M; Abrahamowicz M; Dixon WG
Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):179-186. PubMed ID: 30264875
[TBL] [Abstract][Full Text] [Related]
12. Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study.
Aviña-Zubieta JA; Abrahamowicz M; De Vera MA; Choi HK; Sayre EC; Rahman MM; Sylvestre MP; Wynant W; Esdaile JM; Lacaille D
Rheumatology (Oxford); 2013 Jan; 52(1):68-75. PubMed ID: 23192907
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis.
Pakhchanian H; Khan H; Raiker R; Ahmed S; Kavadichanda C; Abbasi M; Kardeş S; Agarwal V; Aggarwal R; Gupta L
Semin Arthritis Rheum; 2022 Oct; 56():152034. PubMed ID: 35750526
[TBL] [Abstract][Full Text] [Related]
14. Association of Different Prescribing Patterns for Oral Corticosteroids With Fracture Preventive Care Among Older Adults in the UK and Ontario.
Matthewman J; Tadrous M; Mansfield KE; Thiruchelvam D; Redelmeier DA; Cheung AM; Lega IC; Prieto-Alhambra D; Cunliffe LA; Mulick A; Henderson A; Langan SM; Drucker AM
JAMA Dermatol; 2023 Sep; 159(9):961-969. PubMed ID: 37556153
[TBL] [Abstract][Full Text] [Related]
15. The association between pre-exposure to glucocorticoids and other immunosuppressant drugs with severe COVID-19 outcomes.
Brodin R; van der Werff SD; Hedberg P; Färnert A; Nauclér P; Bergman P; Requena-Méndez A
Clin Microbiol Infect; 2022 Nov; 28(11):1477-1485. PubMed ID: 35644344
[TBL] [Abstract][Full Text] [Related]
16. Risk of Incident Diabetes Mellitus Associated With the Dosage and Duration of Oral Glucocorticoid Therapy in Patients With Rheumatoid Arthritis.
Movahedi M; Beauchamp ME; Abrahamowicz M; Ray DW; Michaud K; Pedro S; Dixon WG
Arthritis Rheumatol; 2016 May; 68(5):1089-98. PubMed ID: 26663814
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Glucocorticoid Use and Cancer Risk: A Population-Based Cohort Study in South Korea.
Oh TK; Song IA
Cancer Prev Res (Phila); 2020 Dec; 13(12):1017-1026. PubMed ID: 32839205
[TBL] [Abstract][Full Text] [Related]
18. Perioperative glucocorticoid prescribing habits in patients with inflammatory bowel disease: a call for standardization.
Lamore RF; Hechenbleikner EM; Ha C; Salvatori R; Harris LH; Marohn MR; Gearhart SL; Efron JE; Wick EC
JAMA Surg; 2014 May; 149(5):459-66. PubMed ID: 24647868
[TBL] [Abstract][Full Text] [Related]
19. Influence of initial glucocorticoid co-medication on mortality and hospitalization in early inflammatory arthritis: an investigation by record linkage of clinical and administrative databases.
Sakellariou G; Scirè CA; Rumi F; Carrara G; Zanetti A; Cerra C; Migliazza S; Bugatti S; Montecucco C
Arthritis Res Ther; 2022 Jun; 24(1):144. PubMed ID: 35710524
[TBL] [Abstract][Full Text] [Related]
20. The limitations of using simple definitions of glucocorticoid exposure to predict fracture risk: A cohort study.
Robinson DE; van Staa TP; Dennison EM; Cooper C; Dixon WG
Bone; 2018 Dec; 117():83-90. PubMed ID: 30218790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
